{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:06:49Z","timestamp":1783638409474,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["21430"],"award-info":[{"award-number":["21430"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish state"},{"name":"Swedish government and the county councils","award":["ALFGBG-1005848"],"award-info":[{"award-number":["ALFGBG-1005848"]}]},{"name":"Swedish government and the county councils","award":["ALFGBG-1005820"],"award-info":[{"award-number":["ALFGBG-1005820"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) is common among people with HIV (PWH), although studies comparing T2DM-related complications in people with and without HIV (PWoH) remain limited. This was assessed using data from the Cohort Study on Morbidity and HIV in Sweden (COSMOHS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Nationwide study including Swedish residents born 1930\u20132006, diagnosed with T2DM between 2010 and 2019, followed until 31 December 2024, using 7 national registers including national HIV and diabetes registers. Follow-up began at T2DM diagnosis. Outcomes included renal events, cardiovascular events, and all-cause mortality. Cox proportional regression estimated hazard ratios (adjHRs) by HIV status, stratified by propensity score quintiles of age, sex, migrant status, comorbidities, and socioeconomics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>350 PWH and 311 668 PWoH were included, with similar median follow-up time (PWH, 7.8 years; PWoH, 8.8 years). PWH had higher renal risk than PWoH (major adverse kidney event: adjHR, 2.04; 95% CI, 1.57-2.65) but no significantly increased cardiovascular risk (major adverse cardiovascular event: adjHR, 1.18; 95% CI, .87\u20131.60) or all-cause mortality. Findings were consistent across sensitivity analyses, including competing-risk models for death and excluding PWH receiving tenofovir disoproxil fumarate at baseline. Accounting for the benign plasma\/serum-creatinine increase associated with bictegravir, cobicistat, dolutegravir, and rilpivirine, the increased renal risk remained, although not statistically significant. The renal risk was most prominent in PWH with BMI \u226530 kg\/m2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this nationwide cohort, PWH with T2DM exhibited higher risk of renal complications than PWoH, indicating enhanced renal monitoring may be warranted. Further research should investigate underlying mechanisms, including antiretroviral therapy, to guide clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciag261","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:36:30Z","timestamp":1776339390000},"page":"e1252-e1261","source":"Crossref","is-referenced-by-count":2,"title":["Renal and Cardiovascular Complications Following Type 2 Diabetes Mellitus in People With and Without HIV: Data From the Cohort Study on Morbidity and HIV in Sweden (COSMOHS) Between 2010 and 2024"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4105-2902","authenticated-orcid":false,"given":"Isabela","family":"Killander M\u00f6ller","sequence":"first","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Orthopedics, Lund University , Lund ,","place":["Sweden"]},{"name":"Centre for Clinical Research V\u00e4stmanland, V\u00e4stmanland County Hospital, Uppsala University , V\u00e4ster\u00e5s ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Br\u00e4nnstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, S\u00f6dersjukhuset , Stockholm ,","place":["Sweden"]},{"name":"Department of Clinical Science and Education, Karolinska Institute, S\u00f6dersjukhuset , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tintin","family":"B\u00e4ckdahl","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3799-9869","authenticated-orcid":false,"given":"Olof","family":"Elvstam","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Lund University , Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, V\u00e4xj\u00f6 Hospital , V\u00e4xj\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2357-1020","authenticated-orcid":false,"given":"Magnus","family":"Gissl\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3153-098X","authenticated-orcid":false,"given":"Pontus","family":"Hedberg","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1202-3504","authenticated-orcid":false,"given":"\u00c5sa","family":"Mellgren","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg , Gothenburg ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"M\u00e5nsson","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Lund University , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontus","family":"Naucl\u00e9r","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Spar\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2569-4160","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Eliasson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sahlgrenska University Hospital, Region V\u00e4stra G\u00f6taland , Gothenburg ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9962-5964","authenticated-orcid":false,"given":"Christina","family":"Carlander","sequence":"additional","affiliation":[{"name":"Department of Medicine Huddinge, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet , Stockholm ,","place":["Sweden"]},{"name":"Department of Infectious Diseases, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"2026070722333003600_ciag261-B1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/EDE.0000000000000815","article-title":"Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis","volume":"29","author":"Nansseu","year":"2018","journal-title":"Epidemiology"},{"key":"2026070722333003600_ciag261-B2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12879-025-12222-5","article-title":"Association between HIV infection and type 2 diabetes mellitus: global incidence, prevalence, and risk factors\u2014a systematic review and meta-analysis","volume":"26","author":"Moameri","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026070722333003600_ciag261-B3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","journal-title":"Lancet"},{"key":"2026070722333003600_ciag261-B4","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/QAD.0000000000002922","article-title":"Risk for incident diabetes is greater in prediabetic men with HIV than without HIV","volume":"35","author":"Slama","year":"2021","journal-title":"AIDS"},{"key":"2026070722333003600_ciag261-B5","doi-asserted-by":"crossref","first-page":"e0254079","DOI":"10.1371\/journal.pone.0254079","article-title":"Development of type 2 diabetes and insulin resistance in people with HIV infection: prevalence, incidence and associated factors","volume":"16","author":"Bratt","year":"2021","journal-title":"PLoS One"},{"key":"2026070722333003600_ciag261-B6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/cid\/ciae406","article-title":"Integrase strand transfer inhibitor-related changes in body mass Index and risk of diabetes: a prospective study from the RESPOND Cohort Consortium","volume":"80","author":"Rupasinghe","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026070722333003600_ciag261-B7","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1016\/S2352-3018(24)00183-8","article-title":"Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration","volume":"11","author":"Pantazis","year":"2024","journal-title":"Lancet HIV"},{"key":"2026070722333003600_ciag261-B8","doi-asserted-by":"crossref","first-page":"127580","DOI":"10.1016\/j.vaccine.2025.127580","article-title":"Sociodemographic factors influencing SARS-CoV-2 vaccination uptake in people with and without HIV: insights from a Swedish nationwide cohort","volume":"62","author":"Killander M\u00f6ller","year":"2025","journal-title":"Vaccine"},{"key":"2026070722333003600_ciag261-B9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ije\/dyr029","article-title":"Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis","volume":"40","author":"Agardh","year":"2011","journal-title":"Int J Epidemiol"},{"key":"2026070722333003600_ciag261-B10","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1097\/QAD.0b013e328359a8e5","article-title":"HIV infection and glycemic response to newly initiated diabetic medical therapy","volume":"26","author":"Han","year":"2012","journal-title":"AIDS"},{"key":"2026070722333003600_ciag261-B11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-8587(23)00223-1","article-title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","volume":"11","author":"Emerging Risk Factors Collaboration","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070722333003600_ciag261-B12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"2026070722333003600_ciag261-B13","doi-asserted-by":"crossref","first-page":"100105","DOI":"10.1016\/j.lanepe.2021.100105","article-title":"Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: a nationwide retrospective cohort study","volume":"4","author":"Rawshani","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2026070722333003600_ciag261-B14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2026070722333003600_ciag261-B15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"2026070722333003600_ciag261-B16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10654-025-01221-0","article-title":"Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register","volume":"40","author":"Everhov","year":"2025","journal-title":"Eur J Epidemiol"},{"key":"2026070722333003600_ciag261-B17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2026070722333003600_ciag261-B18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"2026070722333003600_ciag261-B19","author":"Swedish National Board of Health and Welfare"},{"key":"2026070722333003600_ciag261-B20","doi-asserted-by":"crossref","first-page":"e069688","DOI":"10.1136\/bmjopen-2022-069688","article-title":"Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden","volume":"13","author":"Carlander","year":"2023","journal-title":"BMJ Open"},{"key":"2026070722333003600_ciag261-B21","doi-asserted-by":"crossref","first-page":"2400058","DOI":"10.2807\/1560-7917.ES.2024.29.42.2400058","article-title":"Sweden surpasses the UNAIDS 95-95-95 target: estimating HIV-1 incidence, 2003 to 2022","volume":"29","author":"Lundgren","year":"2024","journal-title":"Euro Surveill"},{"key":"2026070722333003600_ciag261-B22"},{"key":"2026070722333003600_ciag261-B23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2337\/dc24-0908","article-title":"Burden and excess risk of adverse outcomes in patients with type 1 diabetes using KDIGO classification: a national cohort study","volume":"48","author":"Makvandi","year":"2025","journal-title":"Diabetes Care"},{"key":"2026070722333003600_ciag261-B24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/CLEP.S282475","article-title":"Adaptation of the Charlson Comorbidity Index for register-based research in Sweden","volume":"13","author":"Ludvigsson","year":"2021","journal-title":"Clin Epidemiol"},{"key":"2026070722333003600_ciag261-B25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An Introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"2026070722333003600_ciag261-B26","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u2018dagitty\u2019","volume":"45","author":"Textor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2026070722333003600_ciag261-B27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1468-1293.2009.00716.x","article-title":"Tenofovir-associated renal and bone toxicity","volume":"10","author":"Woodward","year":"2009","journal-title":"HIV Med"},{"key":"2026070722333003600_ciag261-B28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(17)32340-1","article-title":"Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial","volume":"390","author":"Sax","year":"2017","journal-title":"Lancet"},{"key":"2026070722333003600_ciag261-B29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/QAI.0000000000002275","article-title":"Durable efficacy of dolutegravir plus lamivudine in antiretroviral treatment-naive adults with HIV-1 infection: 96-week results from the GEMINI-1 and GEMINI-2 randomized clinical trials","volume":"83","author":"Cahn","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026070722333003600_ciag261-B30","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0140-6736(12)60917-9","article-title":"Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks","volume":"379","author":"Sax","year":"2012","journal-title":"Lancet"},{"key":"2026070722333003600_ciag261-B31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(11)60936-7","article-title":"Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial","volume":"378","author":"Molina","year":"2011","journal-title":"Lancet"},{"key":"2026070722333003600_ciag261-B32","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/S2352-3018(22)00400-3","article-title":"Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGE(h)IV cohort study","volume":"10","author":"Verheij","year":"2023","journal-title":"Lancet HIV"},{"key":"2026070722333003600_ciag261-B33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.kint.2017.11.007","article-title":"Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"93","author":"Swanepoel","year":"2018","journal-title":"Kidney Int"},{"key":"2026070722333003600_ciag261-B34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/QAI.0b013e31825b70d9","article-title":"Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the veterans aging cohort study","volume":"60","author":"Medapalli","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026070722333003600_ciag261-B35","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"2026070722333003600_ciag261-B36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070722333003600_ciag261-B37","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/cid\/ciad728","article-title":"Cardiovascular disease risk factor control in people with and without HIV","volume":"78","author":"Silverberg","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026070722333003600_ciag261-B38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QAI.0000000000001071","article-title":"Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals","volume":"73","author":"Herrin","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026070722333003600_ciag261-B39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/hiv.70120","article-title":"Major revision version 13.0 of the European AIDS Clinical Society Guidelines 2025","volume":"27","author":"Ambrosioni","year":"2026","journal-title":"HIV Med"},{"key":"2026070722333003600_ciag261-B40","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.2337\/dc26-S011","article-title":"11. Chronic kidney disease and risk management: standards of care in diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","journal-title":"Diabetes Care"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag261\/68109757\/ciag261.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/6\/e1252\/68109757\/ciag261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/6\/e1252\/68109757\/ciag261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:34:27Z","timestamp":1783478067000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/6\/e1252\/8658628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,18]]},"published-print":{"date-parts":[[2026,7,8]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag261","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,15]]},"published":{"date-parts":[[2026,4,18]]}}}